Clinical Trials Directory

Trials / Sponsors / Molecular Partners AG

Molecular Partners AG

Industry · 10 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expr
Large Cell Neuroendocrine Carcinoma, Large Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC), Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Phase 1 / Phase 22026-04-01
RecruitingStudy of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Leukemia, Myeloid, Acute
Phase 1 / Phase 22022-12-29
TerminatedFirst-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
Advanced Malignant Solid Tumor
Phase 12021-10-11
CompletedViral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients
Covid19
Phase 22021-04-01
TerminatedSafety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)
COVID-19
Phase 12020-11-18
CompletedStudy to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12019-09-02
TerminatedMP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
EGFR-mutated NSCLC (Disorder)
Phase 12018-03-22
CompletedFirst-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-p
Neoplasms
Phase 12017-08-08
CompletedA Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma
Multiple Myeloma in Relapse
Phase 1 / Phase 22017-05-23
CompletedFirst-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cance
Neoplasms
Phase 1 / Phase 22014-07-01
Molecular Partners AG — clinical trials (10) · Clinical Trials Directory